Assetmark, Inc Abiomed Inc Transaction History

Assetmark, Inc

  • $34.9 Billion
  • Q3 2024

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 01, 2022
BUY
$242.49 - $301.46 $450,788 - $560,414
1,859 Added 29.99%
8,058 $1.98 Million
Q2 2022

Aug 03, 2022
BUY
$224.73 - $338.64 $600,703 - $905,184
2,673 Added 75.81%
6,199 $1.53 Million
Q1 2022

May 13, 2022
BUY
$277.25 - $366.29 $640,447 - $846,129
2,310 Added 189.97%
3,526 $1.17 Million
Q4 2021

Feb 14, 2022
BUY
$300.63 - $371.35 $363,461 - $448,962
1,209 Added 17271.43%
1,216 $437,000
Q3 2021

Nov 12, 2021
BUY
$310.19 - $376.2 $2,171 - $2,633
7 New
7 $2,000
Q2 2020

Aug 11, 2020
SELL
$141.4 - $257.09 $1,838 - $3,342
-13 Closed
0 $0
Q1 2020

May 12, 2020
SELL
$130.51 - $196.01 $56,902 - $85,460
-436 Reduced 97.1%
13 $2,000
Q4 2019

Feb 11, 2020
BUY
$159.31 - $223.54 $7,009 - $9,835
44 Added 10.86%
449 $77,000
Q3 2019

Nov 13, 2019
BUY
$175.89 - $279.23 $12,839 - $20,383
73 Added 21.99%
405 $72,000
Q2 2019

Aug 14, 2019
SELL
$250.96 - $284.94 $10,289 - $11,682
-41 Reduced 10.99%
332 $86,000
Q1 2019

May 14, 2019
SELL
$276.39 - $362.25 $4,975 - $6,520
-18 Reduced 4.6%
373 $107,000
Q4 2018

Feb 13, 2019
BUY
$281.08 - $444.25 $89,664 - $141,715
319 Added 443.06%
391 $127,000
Q2 2018

Aug 01, 2018
SELL
$278.07 - $446.21 $1,112 - $1,784
-4 Reduced 5.26%
72 $29,000
Q1 2018

May 16, 2018
BUY
$192.49 - $295.85 $5,004 - $7,692
26 Added 52.0%
76 $22,000
Q4 2017

Feb 13, 2018
BUY
$168.78 - $199.74 $843 - $998
5 Added 11.11%
50 $9,000
Q3 2017

Nov 08, 2017
SELL
$145.39 - $168.6 $41,581 - $48,219
-286 Reduced 86.4%
45 $8,000
Q1 2016

Sep 15, 2017
SELL
N/A
-518 Reduced 61.01%
331 $31,000
Q4 2015

Sep 15, 2017
BUY
N/A
849
849 $77,000

Others Institutions Holding ABMD

# of Institutions
12
Shares Held
137K
Call Options Held
0
Put Options Held
0
View Full List

About ABIOMED INC

ABMD Quotes by TradingView
  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Assetmark, Inc Portfolio

Follow Assetmark, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email